Article
A Latent profile and network intervention analysis of psychosomatic symptoms in lung cancer immunotherapy patients.
PloS one - 1 Jan 2026
Zheng Danwen, Gao Hang, Zou Yanfei, Shao Qiuyue, Yu Xinyan, Qiu Lanying, Sun Xiaoli
Abstract excerpt
BACKGROUND: Immune checkpoint inhibitors improve non-small cell lung cancer prognosis but induce complex, heterogeneous psychosomatic symptoms. Traditional symptom-focused approaches fail to capture underlying patient heterogeneity and interaction mechanisms. METHODS: In this cross-sectional study of 971 lung cancer patients undergoing immunotherapy, symptom phenotypes were identified using Latent Profile...
Read the complete abstract on PubMedTopics
- Humans
- Female
- Lung Neoplasms
- Male
- Middle Aged
- Immunotherapy
- Cross-Sectional Studies
